Skip to main content
  • Study: SAPIEN 3 Matches SAVR for Durability and Adverse Events in AS Patients with CKD

    Surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 heart valve are associated with a similar risk of major adverse cardiovascular and renal events and similar durability in patients with chronic kidney disease (CKD) at 5 years, according to an analysis of pooled registry data.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details